354 related articles for article (PubMed ID: 9345025)
1. Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin.
Bunting S; Widmer R; Lipari T; Rangell L; Steinmetz H; Carver-Moore K; Moore MW; Keller GA; de Sauvage FJ
Blood; 1997 Nov; 90(9):3423-9. PubMed ID: 9345025
[TBL] [Abstract][Full Text] [Related]
2. Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin.
Chen J; Herceg-Harjacek L; Groopman JE; Grabarek J
Blood; 1995 Dec; 86(11):4054-62. PubMed ID: 7492761
[TBL] [Abstract][Full Text] [Related]
3. Cytokine production and function in c-mpl-deficient mice: no physiologic role for interleukin-3 in residual megakaryocyte and platelet production.
Gainsford T; Roberts AW; Kimura S; Metcalf D; Dranoff G; Mulligan RC; Begley CG; Robb L; Alexander WS
Blood; 1998 Apr; 91(8):2745-52. PubMed ID: 9531584
[TBL] [Abstract][Full Text] [Related]
4. Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice.
Carver-Moore K; Broxmeyer HE; Luoh SM; Cooper S; Peng J; Burstein SA; Moore MW; de Sauvage FJ
Blood; 1996 Aug; 88(3):803-8. PubMed ID: 8704234
[TBL] [Abstract][Full Text] [Related]
5. The residual megakaryocyte and platelet production in c-mpl-deficient mice is not dependent on the actions of interleukin-6, interleukin-11, or leukemia inhibitory factor.
Gainsford T; Nandurkar H; Metcalf D; Robb L; Begley CG; Alexander WS
Blood; 2000 Jan; 95(2):528-34. PubMed ID: 10627458
[TBL] [Abstract][Full Text] [Related]
6. High-level expression of Mpl in platelets and megakaryocytes is independent of thrombopoietin.
Cohen-Solal K; Vitrat N; Titeux M; Vainchenker W; Wendling F
Blood; 1999 May; 93(9):2859-66. PubMed ID: 10216080
[TBL] [Abstract][Full Text] [Related]
7. IL-3 does not contribute to platelet production in c-Mpl-deficient mice.
Chen Q; Solar G; Eaton DL; de Sauvage FJ
Stem Cells; 1998; 16 Suppl 2():31-6. PubMed ID: 11012175
[TBL] [Abstract][Full Text] [Related]
8. Role of the distal half of the c-Mpl intracellular domain in control of platelet production by thrombopoietin in vivo.
Luoh SM; Stefanich E; Solar G; Steinmetz H; Lipari T; Pestina TI; Jackson CW; de Sauvage FJ
Mol Cell Biol; 2000 Jan; 20(2):507-15. PubMed ID: 10611229
[TBL] [Abstract][Full Text] [Related]
9. Thrombocytopenia in c-mpl-deficient mice.
Gurney AL; Carver-Moore K; de Sauvage FJ; Moore MW
Science; 1994 Sep; 265(5177):1445-7. PubMed ID: 8073287
[TBL] [Abstract][Full Text] [Related]
10. Thrombopoietin stimulates colony-forming unit-megakaryocyte proliferation and megakaryocyte maturation independently of cytokines that signal through the gp130 receptor subunit.
Broudy VC; Lin NL; Fox N; Taga T; Saito M; Kaushansky K
Blood; 1996 Sep; 88(6):2026-32. PubMed ID: 8822921
[TBL] [Abstract][Full Text] [Related]
11. Consequences of GATA-1 deficiency in megakaryocytes and platelets.
Vyas P; Ault K; Jackson CW; Orkin SH; Shivdasani RA
Blood; 1999 May; 93(9):2867-75. PubMed ID: 10216081
[TBL] [Abstract][Full Text] [Related]
12. Interaction of thrombopoietin with the platelet c-mpl receptor in plasma: binding, internalization, stability and pharmacokinetics.
Li J; Xia Y; Kuter DJ
Br J Haematol; 1999 Aug; 106(2):345-56. PubMed ID: 10460590
[TBL] [Abstract][Full Text] [Related]
13. Dose-response effects of pegylated human megakaryocyte growth and development factor on platelet production and function in nonhuman primates.
Harker LA; Marzec UM; Hunt P; Kelly AB; Tomer A; Cheung E; Hanson SR; Stead RB
Blood; 1996 Jul; 88(2):511-21. PubMed ID: 8695799
[TBL] [Abstract][Full Text] [Related]
14. The role of megakaryocyte growth and development factor in terminal stages of thrombopoiesis.
Choi ES; Hokom MM; Chen JL; Skrine J; Faust J; Nichol J; Hunt P
Br J Haematol; 1996 Nov; 95(2):227-33. PubMed ID: 8904874
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of thrombopoietin receptors on human megakaryocytes.
Kuwaki T; Hagiwara T; Yuki C; Kodama I; Kato T; Miyazaki H
FEBS Lett; 1998 May; 427(1):46-50. PubMed ID: 9613597
[TBL] [Abstract][Full Text] [Related]
16. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin.
de Sauvage FJ; Carver-Moore K; Luoh SM; Ryan A; Dowd M; Eaton DL; Moore MW
J Exp Med; 1996 Feb; 183(2):651-6. PubMed ID: 8627177
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the serum concentration of thrombopoietin in thrombocytopenic NF-E2 knockout mice.
Shivdasani RA; Fielder P; Keller GA; Orkin SH; de Sauvage FJ
Blood; 1997 Sep; 90(5):1821-7. PubMed ID: 9292514
[TBL] [Abstract][Full Text] [Related]
18. Regulation of platelet lifespan in the presence and absence of thrombopoietin signaling.
Lebois M; Dowling MR; Gangatirkar P; Hodgkin PD; Kile BT; Alexander WS; Josefsson EC
J Thromb Haemost; 2016 Sep; 14(9):1882-7. PubMed ID: 27344013
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic deficiencies in c-mpl and TPO knockout mice.
Murone M; Carpenter DA; de Sauvage FJ
Stem Cells; 1998; 16(1):1-6. PubMed ID: 9474742
[TBL] [Abstract][Full Text] [Related]
20. c-mpl, the thrombopoietin receptor.
Vainchenker W; Methia N; Debili N; Titeux M; Wendling F
Thromb Haemost; 1995 Jul; 74(1):526-8. PubMed ID: 8578519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]